Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

Universal Infant Immunisation Against Respiratory Syncytial Virus and European Inequalities: The Pandemics Lesson Has Not Been Learnt
2023 · Hôpital Antoine-Béclère AP-HP, · Université Paris-Saclay, · American College of Emergency Physicians, · Hospital General Universitario Gregorio Marañón, · St. Marien Children's Hospital, · University Medical Centre Utrecht, · Respiratory Syncytial Virus NETwork (ReSViNET) Foundation, · University Hospital of Padova
This comment discusses the challenges of implementing universal infant immunization against respiratory syncytial virus (RSV) in Europe. RSV is a major cause of illness in …
Impact of Nirsevimab on Respiratory Syncytial Virus Bronchiolitis in Hospitalized Infants: A Real-World Study
2024 · Groupe de Pathologie Infectieuse Pediatrique, · Université de Montpellier, · Hôpital Femme Mère Enfant Service des Urgences Pédiatriques, · Hôpital Louis Mourier, · Hôpital enfant-adolescent-CHU de Nantes, · Hôpital Antoine-Béclère AP-HP
This study looks at the impact of nirsevimab, a monoclonal antibody, on infants hospitalized with respiratory syncytial virus (RSV) bronchiolitis. It describes how immunized infants …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie